Similarly, experiments with RUNX2 depletion indicated that the inhibition of bone metastasis in breast cancer cells by knockdown of PPARα was dependent on RUNX2, at least partially (Fig. 6E, F). This evidence concerns the gene PPARA and breast cancer.